At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

Four nurses discharged from DR Congo hospital after recovering from virus

While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

Nearly 250 people are suspected to have died, and more than 1,100 are infected with the rare strain of Ebola in the DRC and Uganda, though the true spread of the virus is feared…

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.

There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will…

At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.

With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions

The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine

Amid the spread of the virus in the Democratic Republic of Congo, vaccine development is being fast-tracked